TL;DR: Any suggestions for me, as an EA at arxiv? Do you think this is a potentially impactful role? Why?
The main project: Rewrite arxiv’s 1991 tech (which has some big problems), and run it on GCP.
The role: Lead the big tech decisions and implementation, but not the product decisions, at least not officially. I’ll do this with a good friend, and later on more devs will join.
My fit
Would I enjoy this role? Yes, probably.
Would I be good at it compared to other roles I could do? Yes, probably.
Will I be better for arxiv than their alternative? Yes, I think significantly (they're having a hard time hiring).
Help with Ideas - especially if you think about global priorities
Would you like to have an EA work at arxiv? Why? What could I accomplish? Does this sound like a really high impact opportunity or "just another job"?
Please discuss, my own social circle doesn’t have many people who think about global priorities and I really hope the forum will help me out.
I plan to live-blog this project
For example, “here’s a problem I’m facing, solutions I’m considering, and tradeoffs I see”. Would you like to follow and help me do a better job?
Also, if I do this on Twitter, I hope to get followers from the scientific community around the world and then also tweet EA content. (what do you think?)
Subscribe to this comment to get notified if I start live blogging and on what platform.
Arxiv will probably hire more
Especially in NYC, especially people who’d aim to be the “in house” team and work there for many years.
Subscribe to this comment if you’d like to know when this happens.
Thanks
Feel free to ask things, I tried keeping this post short.
Relatedly, an area where I think arXiv could have a huge impact (in both biosecurity and AI) would be setting standards for easy-to-implement manged access to algorithms and datasets.
This is something called for in Biosecurity in an Age of Open Science:
This sort of idea also appears in New ideas for mitigating biotechnology misuse under responsible access to genetic sequences and in Dual use of artificial-intelligence-powered drug discovery as a proposal for managing risks from algorithmically designed toxins.